Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CDXS — Codexis, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$230,352
+$138,044 QoQ
Shares Held
101,926
+80.0% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CDXS ranks #240 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CDXS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $230,352 101,926
2026-03-31 $92,308 56,631
2025-12-31 $198,908 122,030
2025-09-30 $186,862 76,583
2025-06-30 $107,830 44,193
2025-03-31 $129,823 48,262
2024-12-31 $225,196 47,211
2024-09-30 $98,276 31,908
2024-06-30 $95,365 30,763
2024-03-31 $88,547 25,372
2023-12-31 $71,000 23,279
2023-09-30 $34,669 18,344
2023-06-30 $469,108 167,539
2023-03-31 $62,766 15,161
2022-12-31 $29,245 6,276
2022-09-30 $14,821 2,446
2022-06-30 $127,662 12,205
2022-03-31 $7,409,218 359,322
2021-12-31 $11,068,046 353,951
2021-09-30 $49,740,972 2,138,477
2021-06-30 $45,996,421 2,029,851
2021-03-31 $45,427,698 1,984,609
2020-12-31 $50,626,192 2,319,111
2020-09-30 $28,283,396 2,409,148
2020-06-30 $27,857,085 2,443,604
2020-03-31 $22,980,559 2,059,190